Clinical Trial Update: Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers

View source ↗

Summary

This trial update describes screening methods using digital cognition and blood-based biomarkers to determine eligibility for anti-amyloid treatment in people w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Snippet

Sponsor: MoCA Clinic and Institute | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Status: RECRUITING